medigraphic.com
ISSN 0210-5187 (Digital)

2005, Número 4

<< Anterior Siguiente >>

Med Cutan Iber Lat Am 2005; 33 (4)


Vasculite livedóide com anticorpo antifosfolipídio

Levy BA, Antunes JR, Moritz TB, Ribeiro LME, Cuzzi T, Torres BAC

Idioma: Portugués
Referencias bibliográficas: 20
Paginas: 175-177
Archivo PDF: 249.00 Kb.


RESUMEN

Sin Resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Bard JW, Winkelman RK. Livedo vasculitis: segmental hyalinizing vasculitis of the dermis. Arch Dermatol. 1967;96:489-99.

  2. Milstone LM, Braverman IM, Lucky P, Fleckman P. Classification and therapy of atrophie blanche. Arch Dermatol 1983; 119:963-9.

  3. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol 1999;140:131-5.

  4. Papi M, Didona B, De Pità O, et al. Livedo vasculopathy vs Small Vessel Cutaneous Vasculitis. Arch Dermatol 1998;134:447-52.

  5. Milian G. Les atrophies cutanees syphilitiques. Bull Soc Fr Dermatol Syphilol 1929;36:865-71.

  6. Jorizzo JL. Livedoid Vasculopathy- What is it? Arch Drematol 1998;134:491-3.

  7. Grasland A, Crickx B, Blanc M, Pouchot J, et al. Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies. Ann Med Interne 2000;151:408-10.

  8. McCalmont CS, McCalmont TH, Jorizzo JL, White WL, et al. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol 1992;17:4-8.

  9. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: Additional evidence for abnormal coagulation. J Am Acad Dermatol 2002;46:133-7.

  10. Pizzo Sv, Murray JC, Gonias SL. Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator. Arch Pathol Lab Med 1986;110:517-9.

  11. Schroeter AL, Diaz-Perez J, Winkelmann RK, Jordon RE. Livedo vasculitis (the vasculitis of atrophie Blanche)- Immunohistopathologic study. Arch Dermatol 1975;111:188-93.

  12. Gibson GE, Pittelkow MR. Antiphospholipid syndrome and the skin. J Am Acad Dermatol 1997;36:970 -82.

  13. Drucker CR, Duncan WC. Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol 1982;7:359- 63.

  14. Hsiao GH, Chiu HC. Low-dose danazol in the treatment of livedoid vasculitis. Dermatology. 1997;194:251-5.

  15. Purcell SM, Hayes TJ. Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol 1986;14:851-4.

  16. Jetton RL, Lazarus GS. Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol 1983;8:23- 6.

  17. Choi HJ, Hann SK. Livedo reticularis and livedoid vasculitis responding to PUVA therapy. J Am Acad Dermatol 1999;40: 204-7.

  18. Sauer GC. Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol 1986;22:380 -1.

  19. Sams WM Jr. Livedo vasculitis: therapy with pentoxifylline. Arch Dermatol 1988;124:

  20. 684-7.




2020     |     www.medigraphic.com